Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Probenecid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 104Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sobi & Horizon enter five-year distribution agreement for Ravicti & Ammonaps
    Sobi & Horizon enter five-year distribution agreement for Ravicti & Ammonaps

    07 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/sobi-and-horizon-pharma-enter-five-year-distribution-agreement-for-ravicti-and-ammonaps-outside-the-united-states-300374421.html

    PR NEWSWIRE
    07 Dec 2016
    Share Share
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However

    12 Jan 2015

    // Kurt R. Karst FDA LAW BLOG

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-sides-with-fda-505b2-applicant-in-challenge-to-colchicine-capsules-approval-an-appeal.html

    Kurt R. Karst FDA LAW BLOG
    12 Jan 2015
    Share Share